Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ImmunoGen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next? ↗
Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days. 
Via The Motley Fool
News headline image
TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating ↗
TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. 
Via Investor's Business Daily
News headline image
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals ↗
Wednesday, AbbVie Inc (NYSE: ABBV) agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for a total equity value of approximately $8.7 billion, or $45 per share in cash, with the... 
Via Benzinga
News headline image
Is AbbVie Stock a Buy Now? ↗
AbbVie's business could soon become more diversified. 
Via The Motley Fool
News headline image
Regeneron Pharmaceuticals Stock Sees A Relative Strength Rating Rise ↗
Regeneron Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
News headline image
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch ↗
The Russell 2000 index comprises small-cap companies, exposing investors to small organizations. Consider buying these Russell 2000 stocks. 
Via InvestorPlace
News headline image
Health Care Company AbbVie Announces Acquisition of Immunogen ↗
 
Via Benzinga
News headline image
Where Immunogen Stands With Analysts ↗
 
Via Benzinga
News headline image
ImmunoGen, AbbVie's $10B Deal Comes At 'Right Time' Analyst Says In Downgrade Note ↗
AbbVie Inc (NYSE: ABBV) is acquiring ImmunoGen, Inc. (NASDAQ: IMGN) for around $ 
Via Benzinga
News headline image
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review ↗
Software earnings were strong, while the Fed is shifting toward rate cuts. 
Via Investor's Business Daily
Topics Economy Stocks
News headline image
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
ImmunoGen Stock Nearly Doubled On Thursday: What Happened? ↗
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion. 
Via Talk Markets
News headline image
Why Abbvie Stock Popped Today ↗
The company announces a major deal worth over $10 billion. 
Via The Motley Fool
News headline image
Nasdaq Falls Over 100 Points; Cracker Barrel Shares Slide After Q1 Results ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The... 
Via Benzinga
Topics Stocks
News headline image
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Falls Sharply; Kroger Posts Upbeat Earnings ↗
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P... 
Via Benzinga
Topics Stocks
News headline image
ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal ↗
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC)... 
Via Benzinga
News headline image
Why Is Soligenix (SNGX) Stock Up 285% Today? ↗
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial. 
Via InvestorPlace
News headline image
Minim (MINM) Stock Soars 77% After Receiving Nasdaq Deficiency Notice ↗
Minim stock is taking off with heavy trading of MINM shares on Thursday despite the company getting a delisting warning. 
Via InvestorPlace
News headline image
Why Is ImmunoGen (IMGN) Stock Up 81% Today? ↗
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal. 
Via InvestorPlace
News headline image
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal ↗
IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere. 
Via Investor's Business Daily
News headline image
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
News headline image
Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October ↗
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the... 
Via Benzinga
Topics Economy Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
These Three Biotech Stocks Are Trading At A Discount ↗
Investors exposed to the biotech sector have seen mixed results this year. 
Via Talk Markets
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News ↗
CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level. 
Via Investor's Business Daily
News headline image
Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating ↗
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86. 
Via Investor's Business Daily
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.